Condition: Pulmonary Arterial Hypertension (PAH) · Pulmonary Hypertension, Interstitial Lung Disease · Sponsor: AllRock Bio, Inc.
This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH). Each eligible participant will receive standard of care (SOC) plus ROC-101 for a 24-week treatment period, followed by a long-term extension period of the study through the end of the program or marketing approval/authorization.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Arizona Pulmonary Specialists | Phoenix, Arizona, United States | Recruiting |
| University of California Davis Health | Rancho Cordova, California, United States | Recruiting |
| University of Colorado | Aurora, Colorado, United States | Recruiting |
| George Washington University Medical | Washington D.C., District of Columbia, United States | Recruiting |
| Mayo Clinic of Florida | Jacksonville, Florida, United States | Recruiting |
| The University of Kansas Medical Center Research Institute | Kansas City, Kansas, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Ohio State University | Columbus, Ohio, United States | Recruiting |
| Bend Memorial Clinic | Bend, Oregon, United States | Recruiting |
| Temple University | Philadelphia, Pennsylvania, United States | Recruiting |
| Royal Prince Alfred Hospital | Camperdown, New South Wales, Australia | Recruiting |
| Pulmonary Hypertension Research Queensland | Auchenflower, Queensland, Australia | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07175038